Cheng Edward Y
Department of Orthopaedic Surgery, University of Minnesota, 2512 South 7th Street, R200, Minneapolis, MN 55454, USA.
Hematol Oncol Clin North Am. 2005 Jun;19(3):451-70, v. doi: 10.1016/j.hoc.2005.03.009.
Nearly all bone and soft tissue sarcomas will require surgical management. Early consultation with a surgeon who is experienced in sarcomas, before a biopsy is performed, will avoid potential errors that may complicate subsequent surgery. Advances in imaging, neoadjuvant therapies, and reconstructive techniques have improved the ability to resect adequately most bone and soft tissue sarcomas. The use of oncologic and functional outcomes assessment tools facilitates the development of improved treatments for sarcoma patients. Results from major centers reveal that most patients who have a nonmetastatic bone or soft tissue sarcoma will survive 5 years after surgery when combined with either chemotherapy or radiation.
几乎所有的骨与软组织肉瘤都需要手术治疗。在进行活检之前,尽早咨询一位在肉瘤治疗方面经验丰富的外科医生,可避免可能使后续手术复杂化的潜在失误。影像学、新辅助治疗及重建技术的进展,提高了充分切除大多数骨与软组织肉瘤的能力。肿瘤学和功能预后评估工具的使用,有助于为肉瘤患者开发更好的治疗方法。主要中心的结果显示,大多数患有非转移性骨或软组织肉瘤的患者,在接受手术并结合化疗或放疗后,能够存活5年。